Almindelige bivirkninger, som er indberettet hos mindst 1 ud af 100 patienter i Tygacil behandling men færre end 1 ud af 10 patienter, er: • Bylder (ansamling af pus), infektioner • Laboratoriemålinger af nedsat evne til at danne blodpropper • Svimmelhed • Irritation i blodårerne p. g. a. injektionen, incl. smerte, inflammation, hævelse og størkning • Mavemerter, dyspepsi (mavepine og fordøjelsesbesvær), anoreksi (appetitløshed) • Stigning i leverenzymer, hyperbilirubinæmi (unormal høj koncentration af galdefarvestof i blodet) • Kløe, udslæt • Hovedpine • Stigning i amylase, som er et enzym, der findes i spytkirtlerne og bugspytkirtlen, forhøjet urinkvælstof i blodet
Common side effects reported in at least 1 in 100 patients but in less than 1 in 10 patients receiving Tygacil are: • Abscess (collection of pus), infections • Laboratory measurements of decreased ability to form blood clots • Dizziness • Vein irritations from the injection, including pain, inflammation, swelling and clotting • Abdominal pain, dyspepsia (stomach ache and indigestion), anorexia (loss of appetite) • Increases in liver enzymes, hyperbilirubinaemia (excess of bile pigment in the blood) • Pruritus (itching), rash • Headache • Increase in amylase, which is an enzyme found in the salivary glands and pancreas, increased blood urea nitrogen (BUN).